Zacks Investment Research on MSN

CRISPR Therapeutics AG (CRSP) stock declines while market improves: Some information for investors

In the latest close session, CRISPR Therapeutics AG (CRSP) was down 8.7% at $55.52. The stock fell short of the S&P 500, ...